z-logo
open-access-imgOpen Access
Development of ruxolitinib as a myelofibrosis therapy
Author(s) -
Srđan Verstovšek,
Abdul Kareem Al-Momen,
Kate J. Newberry,
Aamer Aleem
Publication year - 2013
Publication title -
journal of applied hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.107
H-Index - 2
eISSN - 2454-6976
pISSN - 1658-5127
DOI - 10.4103/1658-5127.123299
Subject(s) - ruxolitinib , medicine , myelofibrosis , adverse effect , myeloid , oncology , bone pain , bone marrow

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here